Growth factors as novel therapeutic targets in neoplastic disease.
about
Inhibition of EP2/EP4 signaling abrogates IGF-1R-mediated cancer cell growth: involvement of protein kinase C-θ activation.Evidence for the differential expression of a variant EGF receptor protein in human prostate cancer.Expression of transforming growth factor-alpha in primary human colon and lung carcinomas.
P2860
Growth factors as novel therapeutic targets in neoplastic disease.
description
1988 nî lūn-bûn
@nan
1988 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
1988 թվականի հունվարին հրատարակված գիտական հոդված
@hy
1988年の論文
@ja
1988年論文
@yue
1988年論文
@zh-hant
1988年論文
@zh-hk
1988年論文
@zh-mo
1988年論文
@zh-tw
1988年论文
@wuu
name
Growth factors as novel therapeutic targets in neoplastic disease.
@ast
Growth factors as novel therapeutic targets in neoplastic disease.
@en
type
label
Growth factors as novel therapeutic targets in neoplastic disease.
@ast
Growth factors as novel therapeutic targets in neoplastic disease.
@en
prefLabel
Growth factors as novel therapeutic targets in neoplastic disease.
@ast
Growth factors as novel therapeutic targets in neoplastic disease.
@en
P2093
P1433
P1476
Growth factors as novel therapeutic targets in neoplastic disease.
@en
P2093
P304
P577
1988-01-01T00:00:00Z